The antioxidant N-acetylcysteine protects from lung emphysema but induces lung adenocarcinoma in mice.
Acetylcysteine
/ adverse effects
Adenocarcinoma of Lung
/ chemically induced
Animals
Antioxidants
/ adverse effects
Disease Models, Animal
Female
Humans
Lung
/ pathology
Lung Diseases
/ pathology
Lung Neoplasms
Male
Mice
Mice, Knockout
Oxidative Stress
/ drug effects
Proto-Oncogene Proteins c-jun
/ genetics
Pulmonary Emphysema
/ drug therapy
Reactive Oxygen Species
COPD
Cancer
Lung cancer
Oncology
Pulmonology
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
03 10 2019
03 10 2019
Historique:
received:
24
01
2019
accepted:
31
08
2019
entrez:
4
10
2019
pubmed:
4
10
2019
medline:
21
10
2020
Statut:
epublish
Résumé
Oxidative stress is a major contributor to chronic lung diseases. Antioxidants such as N-acetylcysteine (NAC) are broadly viewed as protective molecules that prevent the mutagenic effects of reactive oxygen species. Antioxidants may, however, increase the risk of some forms of cancer and accelerate lung cancer progression in murine models. Here, we investigated chronic NAC treatment in aging mice displaying lung oxidative stress and cell senescence due to inactivation of the transcription factor JunD, which is downregulated in diseased human lungs. NAC treatment decreased lung oxidative damage and cell senescence and protected from lung emphysema but concomitantly induced the development of lung adenocarcinoma in 50% of JunD-deficient mice and 10% of aged control mice. This finding constitutes the first evidence to our knowledge of a carcinogenic effect of antioxidant therapy in the lungs of aged mice with chronic lung oxidative stress and warrants the utmost caution when considering the therapeutic use of antioxidants.
Identifiants
pubmed: 31578304
pii: 127647
doi: 10.1172/jci.insight.127647
pmc: PMC6795405
doi:
pii:
Substances chimiques
Antioxidants
0
Proto-Oncogene Proteins c-jun
0
Reactive Oxygen Species
0
junD protein, mouse
0
Acetylcysteine
WYQ7N0BPYC
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Crit Rev Food Sci Nutr. 2004;44(4):275-95
pubmed: 15462130
Cell Metab. 2008 Feb;7(2):113-24
pubmed: 18249171
Expert Rev Respir Med. 2016;10(1):89-97
pubmed: 26567752
Respir Med. 2010 May;104(5):758-9
pubmed: 20226648
EMBO Rep. 2009 Mar;10(3):271-7
pubmed: 19197340
Sci Transl Med. 2015 Oct 7;7(308):308re8
pubmed: 26446958
Cancer Res. 2004 Apr 1;64(7):2307-16
pubmed: 15059877
JAMA. 2007 Feb 28;297(8):842-57
pubmed: 17327526
EMBO Mol Med. 2010 Jun;2(6):211-30
pubmed: 20535745
Eur Respir Rev. 2015 Sep;24(137):451-61
pubmed: 26324807
Chest. 2018 Jul;154(1):169-176
pubmed: 29170036
Chest. 2014 Sep;146(3):611-623
pubmed: 24833327
Nat Rev Cancer. 2001 Dec;1(3):203-13
pubmed: 11902575
N Engl J Med. 1994 Apr 14;330(15):1029-35
pubmed: 8127329
Nat Commun. 2014 May 06;5:3792
pubmed: 24797322
Sci Transl Med. 2014 Jan 29;6(221):221ra15
pubmed: 24477002
J Biol Chem. 1999 Mar 19;274(12):7936-40
pubmed: 10075689
Cell. 2004 Sep 17;118(6):781-94
pubmed: 15369676
Pharmacol Ther. 2015 Sep;153:125-34
pubmed: 26096607
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415880
Circulation. 2013 Mar 19;127(11):1229-40, e1-21
pubmed: 23410942
J Natl Cancer Inst. 1993 Sep 15;85(18):1483-92
pubmed: 8360931
Mol Cell. 2000 Nov;6(5):1109-19
pubmed: 11106750